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Introduction
During cell division the mitotic checkpoint minimizes aneu-
ploidy by delaying anaphase and exit from mitosis until all ki-
netochores are stably attached to microtubules (MTs). When the 
checkpoint cannot be satisfied, i.e., in the presence of one or 
more unattached kinetochores, many human cells escape mito-
sis after a prolonged (20 h) delay to form tetraploid G1 cells. 
During this process, termed mitotic slippage, the cyclin B sub-
unit of the cyclin B/CDK1 kinase is slowly destroyed in an 
APC-dependent manner in the presence of an active checkpoint. 
As a result, over time cyclin B/CDK1 activity falls below that 
needed to maintain the mitotic state (Brito and Rieder, 2006).
Taxol is a MT-stabilizing drug currently used to treat vari-
ous cancers. Although its mode of action is unknown, entry into 
mitosis  is  required  for  Taxol  sensitivity  (Sudo  et  al.,  2004) 
where it is thought to induce apoptosis by inhibiting mitotic 
checkpoint  satisfaction. Yet,  when  cultured  human  cells  are 
treated with clinically relevant Taxol concentrations (5–10 nM) 
mitosis is not arrested. Rather, after a few hours the cells satisfy 
the checkpoint and complete division to produce 2–3 daughters 
(Ikui et al., 2005), many of which (depending on the cell type) 
die in G1 (Brito and Rieder, 2009). However, at concentrations 
between 50 and 100 nM, Taxol is widely reported to arrest cells in 
mitosis until they die or escape via mitotic slippage (Gascoigne 
and Taylor 2008; Shi et al., 2008).
We recently found that when mitotic checkpoint satisfac-
tion is prevented with nocodazole or Eg5 motor protein inhibi-
tors, human telomerase-immortalized RPE1 cells average 20 h   
in mitosis before slipping into G1. At the same time, however, 
we noted that in 500 nM Taxol RPE1 averaged just 12 h in mi-
tosis, and this shortened duration of mitosis (DM) could not be 
attributed to MT assembly, which occurs also in Eg5 inhibitors. 
We therefore hypothesized that RPE1 cells ultimately satisfy 
the checkpoint in 500 nM Taxol as they do in 5 nM Taxol (Brito 
et al., 2008). To explore this issue further we conducted live 
cell studies to determine the relationship between Taxol con-
centration, the DM, and the mitotic checkpoint.
T
o determine why the duration of mitosis (DM) is less 
in Taxol than in nocodazole or Eg5 inhibitors we 
studied the relationship between Taxol concentra-
tion, the DM, and the mitotic checkpoint. We found that 
unlike for other spindle poisons, in Taxol the DM becomes 
progressively  shorter  as  the  concentration  surpasses   
0.5 µM. Studies on RPE1 and PtK2 expressing GFP/ 
cyclin B or YFP/Mad2 revealed that cells ultimately satisfy 
the checkpoint in Taxol and do so faster at concentrations 
>0.5 µM. Inhibiting the aurora-B kinase in Taxol-treated 
RPE1 cells accelerates checkpoint satisfaction by stabiliz-
ing syntelic kinetochore attachments and reduces the DM 
to 1.5 h regardless of drug concentration. A similar sta-
bilization of syntelic attachments by Taxol itself appears 
responsible for accelerated checkpoint satisfaction at con-
centrations >0.5 µM. Our results provide a novel concep-
tual framework for how Taxol prolongs mitosis and caution 
against using it in checkpoint studies. They also offer an 
explanation for why some cells are more sensitive to lower 
versus higher Taxol concentrations.
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off-site target(s) independent of MTs. To test this we treated 
RPE1 for 3 h with 3.2 µM nocodazole to prevent MT assembly, 
and then added 5 µM Taxol. We reasoned that if in the absence 
of MTs 5 µM Taxol still drives cells from mitosis in 5 h, then 
there is an off-site target involved. However, even in 3.2 µM no-
codazole 5 µM Taxol stimulated MT assembly (unpublished 
data). We therefore modified this experiment by locking tubulin 
into paracrystals with 10 µM vinblastine before adding 5 µM 
Taxol. Under this condition MT formation was inhibited and the 
cells remained in mitosis for 27 h, similar to after vinblastine 
treatment alone (Fig. 1 G; Table S1). Thus, the DM is reduced 
in Taxol concentrations >0.5 µM because of how the drug influ-
ences spindle MTs.
Cells satisfy the mitotic checkpoint in 
Taxol and do so more rapidly at high 
concentrations
Another idea for why the DM versus concentration plot in Taxol 
is biphasic is that cells satisfy the checkpoint in Taxol, but do so 
faster at high concentrations. This is suggested by our data that 
the DM in 5 nM to 10 µM Taxol is much less than the 20 h seen 
in cells that cannot satisfy the checkpoint (above). The unchal-
lenged assumption that, as for agents that inhibit MT assembly, 
Taxol at >100 nM prevents checkpoint satisfaction comes from 
reports that at these concentrations: (1) spindle assembly is 
Results and discussion
For drugs that prevent MT assembly or centrosome separation 
the DM increases with concentration to a point after which it no 
longer changes. For HeLa this point ranges from 6 nM in vin-
blastine to 100 nM in nocodazole (Jordan et al., 1992), and 1.5 µM 
in S-Trityl-l-cysteine (an Eg5 inhibitor; Skoufias et al., 2006). 
Here, we report that this relationship does not exist for Taxol and 
its analogues: although the DM in RPE1 cells treated with 5, 50, 
or 500 nM Taxol increased from 2.5 h to 12 h, in 5 and 10 µM 
Taxol mitosis averaged, respectively, just 5 and 3.5 h and 99% of 
the cells survived (Fig. 1 B; Table S1). The same was true for the 
Taxol analogue epothilone B (Fig. 1 C). This hitherto unreported 
response to Taxol was also seen in normal human BJ fibroblasts 
and rat kangaroo kidney (PtK2) cells, and to a lesser extent in 
HeLa and U2OS (Fig. 1, D–F; Table S1). Thus, unlike drugs that 
inhibit MT assembly or centrosome separation, the dose–response 
curve for the DM in drugs that promote MT stability is biphasic, 
increasing to a point after which it decreases.
Accelerated exit from mitosis in Taxol 
concentrations >0.5 µM is due to a drug 
effect on spindle microtubules
Why is the DM in 5 µM Taxol less than in 0.5 µM Taxol? One 
idea is that at high concentrations Taxol and epothilone B have 
Figure 1.  The duration of mitosis increases with Taxol concentration until a point after which it decreases. (A–F) Duration of mitosis vs. drug concentration 
for RPE1 cells treated with nocodazole, Taxol, or Epothilone B, and for PtK2, human BJ fibroblasts, and HeLa cells treated with Taxol. (G) 5 µM Taxol does 
not shorten mitosis in RPE1 if microtubule assembly is first prevented by vinblastine.677 TAXOL AND THE MITOTIC CHECKPOINT • Yang et al.
occurred shortly after a sudden precipitous drop in cyclin B/GFP 
fluorescence (Fig. 3, B and D). This result confirms that, as for 
PtK2, RPE1 exit from mitosis in ≥5 µM Taxol is due to check-
point satisfaction.
Although our Mad2 data (Fig. S1) suggest that like PtK2, 
RPE1 also satisfy the checkpoint in 0.5 µM Taxol, attempts to 
demonstrate this by cyclin B/GFP degradation gave results dif-
ficult to interpret (Fig. 3 D). However, as for other cell types, in 
a given spindle poison the DM in RPE1 is highly variable: e.g., 
744 ± 399 min for 0.5 µM Taxol and 1218 ± 424 min in dimeth-
ylenastron (Brito et al., 2008). Thus, although some cells may 
slip through mitosis in 0.5 µM Taxol before checkpoint satis-
faction, the significantly reduced average DM in 0.5 µM Taxol 
(12 h) compared with when the checkpoint cannot be satisfied 
(20 h) suggests that most RPE1 satisfy the checkpoint in   
0.5 µM Taxol.
As previously reported for PtK (Waters et al., 1998), we 
found no tension on centromeres in PtK2 or RPE1 dividing in 
0.5–10 µM Taxol (Fig. S2). However, in 10 µM Taxol the cells 
satisfy the mitotic checkpoint in just several hours. Thus, as 
concluded recently by others (O’Connell et al., 2008; Uchida   
et al., 2009), production of the checkpoint signal is not due to a 
lack of tension on the centromere. That is, there is no centromere-
based Mad2-independent tension-sensing pathway for main-
taining the checkpoint in the absence of tension between sister 
kinetochores (Skoufias et al., 2001; Ahonen et al., 2005).
In Taxol, checkpoint satisfaction is delayed 
until all monotelic and syntelic attachments 
are converted into amphitelic or stable 
syntelic attachments
The spindle assembly pathway in Taxol differs from that in un-
treated cells: in the latter, kinetochore attachment occurs over 
15–20 min (Fig. 2 A) from a search-and-capture process, depen-
dent on MT dynamics which is facilitated by the motion of 
chromosomes and asters (Kapoor et al., 2006; Cai et al., 2009). 
By contrast, as cells enter mitosis in >100 nM Taxol they form 
many small asters that migrate at NEB to the chromosomes, 
where they form a large multipolar spindle (Maekawa et al., 
1991; Hornick et al., 2008) (Fig. 4 A). Under this condition as-
tral MTs are substantially shorter, their dynamics are depressed, 
and the chromosomes are immobile. As a result, the rate kineto-
chores attach to MTs in Taxol is retarded because it is defined 
by the movement of the asters and not the dynamic behavior of 
their associated MTs or chromosomes.
As in a normal mitosis, in Taxol many chromosomes be-
come attached to an aster in a monotelic or syntelic fashion 
(Fig. 4, A, F, and G, arrowheads). In untreated cells, syntelic 
attachments are corrected by a constitutive mechanism involv-
ing chromosomal passenger complexes, composed of aurora B, 
survivin,  borealin,  and  INCENP,  located  in  the  centromere 
(Ruchaud et al., 2007). The correction of a syntelic attachment 
leads to the transient production of a monotelic chromosome 
with an unattached (and thus checkpoint signaling) kinetochore 
(Tanaka et al., 2002; Pinsky et al., 2006). In cells containing 
many syntelic chromosomes but MTs with normal dynamics, 
as on monastrol spindles formed in Eg5 inhibitors (Kapoor   
grossly perturbed, (2) cells are delayed in mitosis, and (3) ki-
netochores are always present in fixed cells that are positive for 
the Mad2 checkpoint protein (Waters et al., 1998). However, the 
checkpoint detects unattached kinetochores, not perturbations 
in spindle assembly, and it can be satisfied on grossly abnormal 
spindles (Ikui et al., 2005; Brito et al., 2008). Also, exit from 
mitosis due to checkpoint satisfaction differs mechanistically 
from slippage (Brito and Rieder, 2006). Finally, cells lacking 
Mad2 at kinetochores would rarely be encountered in Taxol-
treated cultures because as this condition occurs the cells rap-
idly exit mitosis.
Mad2 binds to unattached kinetochores (Chen et al., 1996) 
and is lost from kinetochores as they acquire MTs (Waters et al., 
1998; Nicklas et al., 2001). Because checkpoint satisfaction co-
incides with loss of Mad2 from all kinetochores (Hoffman et al., 
2001), we asked if Mad2 is ultimately lost from all kinetochores 
in Taxol. To answer this we treated RPE1 for 12 h (the average 
DM in 0.5 µM Taxol) with 0.5 or 10 µM Taxol and then added a 
proteasome inhibitor (10 µM MG132) 2 h before fixation and 
Mad2 staining. We reasoned that if in Taxol cells satisfy the 
checkpoint before exiting mitosis, then preventing exit should 
enrich for cells lacking Mad2 at all kinetochores. Indeed, al-
though most cells in each concentration exhibited varying de-
grees of kinetochore-Mad2 staining, cells could be readily 
located in both in which all kinetochores lacked Mad2 (Fig. S1). 
These indirect data suggest that cells satisfy the checkpoint in 
0.5–10 µM Taxol before escaping mitosis.
To directly verify this we followed PtK2 stably expressing 
Mad2/YFP (Mad2/PtK2) as they entered mitosis in 0.5 or 20 µM 
Taxol. The DM in these cells, i.e., the period from nuclear enve-
lope breakdown (NEB) to the initiation of cytokinesis, was 45 ± 
8 min (n = 40), and the period between loss of Mad2/YFP on the 
last kinetochore and the start of cytokinesis was 17 ± 3 min (n = 
16). In 0.5 µM Taxol Mad/PtK2 cells averaged 140 ± 39 min   
(n = 92) in mitosis versus 97 ± 25 min (n = 54) in 20 µM Taxol. 
We found, in all cases and in both drug concentrations, that 
Mad2/PtK2 remained in mitosis until the last kinetochore had 
stably lost its Mad2 signal, 20 min after which an aborted cy-
tokinesis began (Fig. 2, A–C). Also, in both concentrations 85–
90% of the kinetochores lost their Mad2 staining within 40 min 
of NEB, so that the checkpoint was maintained by those few 
that required longer to become stably depleted of Mad2 (Fig. 2, 
D–G). From these direct data we conclude that exit from mito-
sis in Taxol-treated PtK2 cells occurs over a broad (0.5–20 µM) 
range of concentrations from checkpoint satisfaction.
Checkpoint satisfaction can also be inferred from a sud-
den steep drop in cyclin B/GFP fluorescence intensity just be-
fore (Chang et al., 2003) or at (Clute and Pines, 1999) chromatid 
disjunction (Fig. 3, A and D). We therefore followed GFP fluo-
rescence intensity in RPE1 transiently expressing low levels of 
cyclin B/GFP as they entered mitosis in 0.5 to 10 µM Taxol. 
These data were then analyzed to determine if cyclin B/GFP 
decreased at a “background” level until the cell slipped through 
mitosis (Brito and Rieder, 2006), or if it slowly decreased as 
during slippage but then rapidly fell just before mitotic exit as 
for checkpoint satisfaction in 5 nM Taxol (Brito et al., 2008). In 
all five cells examined in both 5 and 10 µM Taxol, mitotic exit JCB • VOLUME 186 • NUMBER 5 • 2009   678
Figure 2.  In Taxol, Mad2 is progressively depleted from kinetochores until the checkpoint is satisfied (see also Fig. S1). (A–C) YFP/Mad2-PtK2 cells were 
followed without treatment (A) or in 0.5 (B) or 20 µM (C) Taxol. Top rows are phase-contrast images and bottom rows are maximum intensity projected YFP 
fluorescence images of the same cell. Exit from mitosis occurs only after the last Mad2-positive kinetochore (A and C, arrowhead) loses its Mad2. (B) In 
0.5 µM Taxol a kinetochore (arrowhead) can lose and then reacquire Mad2, as shown in high-magnification images from the boxed regions. Membrane 
blebbing is typical as cells exit mitosis in Taxol (C) and is not due to apoptosis. (D) Time vs. average number of Mad2-positive kinetochores in controls and 
after treatment with 10 µM nocodazole or 20 µM Taxol. (E–G) Similar plots of individual controls (E), or cells treated with 0.5 µM (F) or 20 µM Taxol (G). 
The number of Mad2-positive kinetochores often transiently increases in 0.5 µM but not 20 µM Taxol.679 TAXOL AND THE MITOTIC CHECKPOINT • Yang et al.
predicted to be promoted by the stabilizing effects of Taxol on 
kinetochore MTs.
Stabilizing syntelic attachments in Taxol 
accelerates exit from mitosis by promoting 
mitotic checkpoint satisfaction
As on monastrol spindles (above), inhibiting aurora B in Taxol-
treated cells accelerates exit from mitosis. We find, in fact, that 
inhibiting aurora B in RPE1 treated with 0.5 µM Taxol reduces 
the DM by 90% (from 12 to 1.5 h; Table S1). An obvious ex-
planation for this is that as in Eg5 inhibitors, inhibiting aurora B 
in Taxol promotes checkpoint satisfaction by stabilizing syn-
telic attachments. However, others have concluded that inhibit-
ing aurora B drives cells treated with Taxol or Eg5 inhibitors 
from mitosis because its activity is required for a functional mi-
totic checkpoint. Although the supporting data are indirect, the 
et al., 2000), checkpoint satisfaction is prevented because error 
correction promotes a continuous cycling between syntelic 
(nonsignaling) and monotelic (signaling) states (Lampson   
et al., 2004). As a result, killing the correction mechanism in 
these cells with aurora B inhibitors rapidly stabilizes all syn-
telic attachments (Hauf et al., 2003;Lampson et al., 2004;   
Loncarek et al., 2007), which leads to Mad2 depletion at all 
kinetochores and checkpoint satisfaction (Hauf et al., 2003; 
Lens et al., 2003).
As in Eg5 inhibitors, the checkpoint cannot be satisfied in 
Taxol until the asters have gathered all the chromosomes, and 
then not until all monotelic attachments are converted either 
into “normal” amphitelic attachments or into syntelic attach-
ments that are somehow stabilized. Although the former pro-
cess is retarded by the Taxol-induced reduction in aster MT 
dynamics and inhibition of chromosome motility, the latter is 
Figure 3.  Cyclin B/GFP fluorescence decay increases 
sharply just before Taxol-treated RPE1 cells exit mito-
sis. (A) In controls, cyclin B/GFP fluorescence exhibits 
a sudden, sharp, continuous drop several minutes be-
fore chromatid disjunction or cytokinesis (D, arrow), 
which is clear from the time vs. cyclin B/GFP intensity 
plot (D). A similar sudden sharp drop in cyclin B/GFP 
fluorescence is also seen shortly before cells treated 
with 10 µM Taxol (B) or 10 µM Taxol and 100 nM 
Hesperadin (C) exit mitosis. (D) Typical normalized 
cyclin B/GFP fluorescence intensity vs. time plots of 
controls or cells treated with 3.2 µM nocodazole, 0.5, 
5, or 10 µM Taxol, or 10 µM Taxol and Hesperadin. 
Plots of cyclin B decay in 0.5 µM Taxol were difficult 
to interpret. Time is in h:min.JCB • VOLUME 186 • NUMBER 5 • 2009   680
However,  one  can  argue  that  the  nocodazole  concentrations 
used (330–660 nM) were insufficient to completely disrupt MT 
assembly, and instead promoted the formation of monopolar 
best evidence for this are reports that inhibiting aurora B in   
nocodazole-treated cells chases them from mitosis prematurely 
(Ditchfield et al., 2003; Hauf et al., 2003; Vader et al., 2007). 
Figure 4.  Chromosomes acquire monotelic, merotelic, or syntelic attachments to asters during spindle assembly in Taxol. (A) 12 serial sections through a 
RPE1 cell from a culture treated for 5 h with 0.5 µM Taxol before fixation and staining for kinetochores (Hec1) and MTs (-tubulin). Although some kineto-
chore pairs have acquired amphitelic attachments to adjacent asters (sections 7 and 12, bottom box), others exhibit monotelic (section 16, right-hand box), 
merotelic (section 13, box), or syntelic (section 7, top box) attachments. (B–D) Inhibiting aurora B does not diminish Mad2 accumulation on kinetochores 
of nocodazole-treated cells. RPE1 cells were treated for 10 h with 3.2 µM nocodazole (B) or 3.2 µM nocodazole and 100 nM Hesperadin (C) before fixa-
tion and staining for centromeres (ACA) and Mad2. (D) The kinetochore-Mad2 staining intensity was found by the Student’s t-test to be the same for both 
conditions. (E–G) When aurora B is inhibited, Mad2 is progressively depleted from kinetochores in Taxol-treated cells. RPE1cultures were incubated in Taxol 
(0.5 µM or 10 µM) and Hesperadin for 3–8 h and 10 µM MG132 was added 2 h before fixation and staining for centromeres and Mad2. Although most 
cells exhibited variable amounts of kinetochore-Mad2 (E), others could readily be located under both conditions which had no kinetochore-Mad2 staining 
(F and G). Arrowheads in F and G note clear syntelic chromosomes.681 TAXOL AND THE MITOTIC CHECKPOINT • Yang et al.
kinetochores from syntelic attachments. To test this we asked if, 
in 500 nM Taxol, Mad2 can suddenly and transiently reappear 
on a kinetochore after it had lost its Mad2, as would occur dur-
ing the correction and reformation of a syntelic attachment. We 
found that this does indeed occur in 0.5 µM Taxol (Fig. 2 B) and 
it leads to transient increases in the number of Mad2-positive 
kinetochores (Fig. 2 F). That this behavior was not seen in 20 µM 
Taxol (Fig. 2 G) implies that the correction mechanism is atten-
uated at elevated Taxol concentrations.
One prediction of our model is that inhibiting aurora B in 
Taxol-treated cells should, by stabilizing syntelic attachments, 
lead to a similar DM regardless of the drug concentration, and 
this too is the case: inhibiting aurora B in RPE1 treated with 0.5 
or 10 µM Taxol decreases the DM from, respectively, 12 and 3.5 h 
to just 1.5 h (Table S1). Under these conditions, exit from mito-
sis coincides both with the depletion of YFP/Mad2 from the last 
Mad2-positive kinetochore (Fig. 5 D) and a sudden, rapid in-
crease in the rate of cyclin B degradation (Fig. 3, C and D), i.e., 
from checkpoint satisfaction.
In summary, our results support a model in which Taxol 
delays cells in mitosis until the last monotelic chromosome es-
tablishes a normal amphitelic connection to an adjacent aster, 
which satisfies the mitotic checkpoint. As the Taxol concentra-
tion increases this event is progressively delayed due to the pro-
gressive inhibition of chromosome motion and MT dynamics. 
Then, at some point a concentration is reached in which further 
increases accelerate checkpoint satisfaction by making it more 
difficult to generate free (signaling) kinetochores from syntelic 
attachments formed in the drug. Although it is unclear how high 
Taxol concentrations stabilize syntelic attachments, it is note-
worthy that as syntely is corrected the kinetochore that loses its 
MT attachment to a spindle pole (aster) remains oriented toward 
that pole because external forces are not present to move it to 
the opposite side of the centromere (Loncarek et al., 2007). 
Thus, even if the error correction mechanism breaks the MT at-
tachments on a given kinetochore in >0.5 µM Taxol, e.g., by 
preventing Hec1 from binding MTs (DeLuca et al., 2006), the 
attachment should rapidly reform as the old Taxol-stabilized ki-
netochore fiber MTs are re-bound.
A reason why some cells are more 
sensitive to lower versus higher Taxol 
concentrations
We found that although 27% of RPE1 cells died in or shortly after 
mitosis in 0.5 µM Taxol (Brito and Rieder, 2009), only 1% died 
in 5–10 µM Taxol—and the same was true for epothilone B 
(Table S1). Similarly, Gascoigne and Taylor (2008) reported 
that almost all H1703 cells die during mitosis in 100 nM Taxol, 
whereas in 10 µM Taxol 63% escape as viable cells. In an ear-
lier but more thorough study, Yeung et al. (1999) noted that after 
24 h in 50 nM Taxol the mitotic index in four of six breast can-
cer lines ranged from 66–82%, and by 48 h 59–79% of the cells 
had died by apoptosis. However, after 24 h in 25 µM Taxol these 
same lines exhibited both a significantly lower mitotic index 
(6–15%) and a dramatic reduction (4–12%) in apoptosis. Thus, 
unlike for other spindle poisons some cells are, paradoxically, 
more sensitive to lower versus higher Taxol concentrations.
spindles containing up to 75% of the normal MT mass (Brinkley   
et al., 1967; Jordan et al., 1992).
If aurora B activity is required for the mitotic checkpoint, 
then inhibiting it in cells lacking MTs should induce exit from 
mitosis in 30 min, as when bona fide checkpoint components 
are depleted or inhibited. To test this, we followed RPE1 cells 
entering mitosis in 3.2 µM nocodazole and a Hesperadin con-
centration (100 nM) that inhibits aurora B (Hauf et al., 2003). 
We found that these cells average 17 h in mitosis, similar to the 
19 h seen after nocodazole treatment alone (Table S1), and that 
Mad2 accumulated on kinetochores in these cells to the same 
level as after nocodazole alone (Fig. 4, B–D). We also found 
that inhibiting aurora B did not prevent YFP/Mad2 from accu-
mulating on kinetochores in nocodazole-treated PtK2 cells   
(Fig. 5 B), and when Hesperadin-treated metaphase PtK2 cells 
lacking Mad2 at most kinetochores were exposed to nocodazole, 
Mad2 rapidly reappeared at the kinetochores (Fig. 5 C). Together, 
these findings reveal that aurora B activity is not required for 
recruitment of Mad2 to kinetochores or for proper mitotic 
checkpoint function.
Mad2 also accumulates on kinetochores as Taxol (0.5–20 
µM)-treated RPE1 (Fig. 4 E) and PtK2 (Fig. 5 D) cells enter mi-
tosis in Hesperadin but, as for cells treated with Taxol only (Fig. 2, 
B and C), Mad2 is then progressively lost from all kinetochores 
after which the cells exit mitosis (Fig. 4, F and G; Fig. 5 D). Be-
cause the 90% reduction in the DM after inhibiting aurora B in 
Taxol-treated RPE1 cells is not due to a requirement for aurora B 
in the checkpoint (above), and because this accelerated exit does 
not occur in the presence of unattached (Mad2-positive) kineto-
chores, it must be due, as on monastrol spindles, to the depletion 
of free kinetochores via the stabilization of syntelic attachments 
(Fig. 4, F and G, arrowheads).
Elevated Taxol concentrations accelerate 
checkpoint satisfaction by stabilizing 
syntelic kinetochore attachments
In Taxol, progressive concentration increases stabilize MTs by 
inhibiting plus- and then minus-end MT dynamics in vitro (Derry 
et al., 1995, 1998) and in vivo (Jordan et al., 1993) until a point 
above which MT assembly is promoted. In HeLa, spindle MT 
mass begins to increase above 10 nM Taxol until it peaks at   
330 nM, 500% above normal (Jordan et al., 1993). This is likely 
true for other cells, although the concentration for inducing maxi-
mum spindle MT mass may differ. Thus, in RPE1, checkpoint sat-
isfaction may occur more rapidly in 5 vs. 0.5 µM Taxol because   
5 µM promotes the formation of more MTs for recruitment by ki-
netochores. However, this cannot be the full story because in RPE1 
increasing Taxol from 5 to 10 µM is unlikely to increase spindle 
MT mass, yet it decreases the DM from 5 to 3.5 h (Fig. 1).
As noted above, in Taxol the mitotic checkpoint cannot be 
satisfied until all kinetochores become stably attached to MTs, 
i.e., until existing monotelic and syntelic attachments are con-
verted into amphitelic attachments or stable syntelic attach-
ments. This being the case, an attractive explanation for why the 
DM is shorter in 5–10 µM versus 0.5 µM Taxol is that after a 
point, further concentration increases make it progressively more 
difficult for the error correction mechanism to produce free   JCB • VOLUME 186 • NUMBER 5 • 2009   682
finding that the DM in high Taxol concentrations is much shorter 
than in lower ones provides a potential explanation for the above 
paradox: for some cell types the delay in mitosis induced by 100–
500 nM Taxol is long enough to trigger the death switch, whereas 
at higher concentrations the cells escape mitosis before this point.
In general, the longer the mitotic checkpoint delays a cell in 
mitosis the more likely it is to die during or after mitosis. This 
implies that a “death switch” is thrown at some point during the 
prolonged mitosis after which the cell is destined to die (Rieder 
and Maiato, 2004; Tao et al., 2005). This being the case, our 
Figure 5.  Inhibiting aurora B with Hesperadin does not prevent Mad2 accumulation at kinetochores in nocodazole-treated Mad2/PtK2 cells. (A and B) 
Mad2 rapidly reappears on kinetochores when Hesperadin-treated cells in metaphase are exposed to nocodazole (C). (D) By contrast, although Mad2 
also accumulates at kinetochores as Taxol-treated cells enter mitosis in Hesperadin, it is depleted with time until all kinetochores lack Mad2 after which the 
cell exits mitosis (see also Fig. 2, C and D).683 TAXOL AND THE MITOTIC CHECKPOINT • Yang et al.
normalizing the value from cells treated with nocodazole plus Hesperadin 
accordingly. Integrated intensities were measured by ImageJ and the 
results were processed by Microsoft Excel software.
Online supplemental material
Table S1 summarizes how the duration of mitosis changes in RPE1, BJ 
fibroblasts, HeLa, and U2OS in response to various drug treatments.   
Fig. S1 documents the progressive depletion of Mad2 from kinetochores in 
Taxol-treated RPE1 cells when exit from mitosis is inhibited with MG132. 
Fig. S2 documents the lack of tension on centromeres in Taxol- treated 
REP1 and PtK2 cells under conditions in which the mitotic checkpoint is 
satisfied.  Online  supplemental  material  is  available  at  http://www.jcb 
.org/cgi/content/full/jcb.200906150/DC1.
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Materials and methods
Cell culture
RPE1, BJ fibroblasts, HeLa, and U2OS were cultured in DME supplemented 
with 10% fetal bovine serum. PtK2 cells stably expressing Mad2-YFP were 
cultured in Ham’s F12 medium (Invitrogen) supplemented with 10% fetal 
bovine serum. Cells were maintained at 37°C in a 5% CO2 atmosphere 
and seeded onto coverslips 24–48 h before experimentation. All drugs 
were diluted in DMSO. Paclitaxel, vinblastine, and epothilone B were from 
Sigma-Aldrich, nocodazole and MG132 were from EMD.
Light microscopy
Immunostaining was as described previously (Brito et al., 2008). Rabbit 
anti-Mad2 antibody (a gift from E.D. Salmon, Chapel Hill, NC) was used 
at 1:400; human anti-centromere antibody (ACA) was used at 1:300 (Anti-
bodies, Inc.); rat anti–-tubulin antibody (YL1/2) was used at 1:5,000 
(Novus  Biologicals  Inc.),  and  mouse  anti-Hec1  (9g3.23)  was  used  at 
1:1,000 (Novus Biologicals, Inc.). DNA was stained with Hoechst 33342 
(Invitrogen). Anti–human Alexa Fluor 488, anti–mouse Alexa Fluor 488, 
and anti-–rabbit Alexa Fluor 546 (Invitrogen) were used at 1:500. Image 
stacks were acquired on a DeltaVision System (Applied Precision, LLC) 
centered on a microscope (model IX70; Olympus) and a camera (model 
CM350; Photometrics). Z-series image stacks were deblurred using the 
SoftWoRx 2.5 deconvolution algorithm (Applied Precision, LLC) and pre-
sented as maximal intensity projections.
For live cell imaging, coverslip cultures were mounted in Rose cham-
bers and maintained at 37°C in phenol-free L-15 medium (Invitrogen) with 
10% fetal bovine serum. For studies on the DM time-lapse phase-contrast 
images were acquired at 1–5-min intervals with a 20X (0.50 NA) Plan-
Fluor objective mounted on an Eclipse TE 2000-U microscope (Nikon) or a 
10X (0.25 NA) PlanFluor objective mounted on a DIAPHOT 200 micro-
scope (Nikon). These microscopes were equipped with ORCA-ER cooled-
CCD (Hamamatsu Photonics) or Micromax (Roper Scientific) cameras, and 
the imaging systems were driven by Image-Pro Plus 5.1 (Media Cybernet-
ics, Inc.).
For studies on kinetochore-associated Mad2-YFP we used a 100× 
1.4 NA PlanApo objective lens mounted on a microscope (model TE 2000-
U; Nikon) equipped with a camera (Cascade 512B; Photometrics). Z-series 
image stacks were collected in both phase-contrast and YFP epifluores-
cence at 1-µm steps throughout the depth of the cell. A narrow band-pass 
excitation filter was used to minimize the photobleaching. The cyclin B/
GFP  studies  were  conducted  as  detailed  previously  (Brito  and  Rieder, 
2006; Brito et al., 2008). In brief, coverslip cultures of RPE1 cells were 
transfected with a cyclin B/GFP plasmid (a gift of Jon Pines, University of 
Cambridge, Cambridge, UK), after which they were returned to a 37°C in-
cubator. 15 h later the coverslips were mounted in Rose chambers contain-
ing various concentrations of Taxol. These were then placed on the stage 
of a microscope (model TE2000E; Nikon) maintained at 37°C. Cyclin B/
GFP–expressing  prophase  cells  were  located  and  followed  into  and 
through mitosis using a 40X 0.75 NA lens. Near-simultaneous phase- 
contrast and fluorescence images were acquired at 1–5-min intervals using 
a shuttered camera (Orca ER; Hamamatsu Photonics) as well as a narrow 
band-pass excitation filter for minimizing GFP photobleaching. Integrated 
fluorescence intensities were measured using ImageJ (National Institutes of 
Health,  Bethesda,  MD)  and  the  method  described  by  Hoffman  et  al. 
(2001). Surrounding interphase cells expressing cyclin B/GFP were used 
as photobleaching controls, and all intensities were normalized as the ratio 
to the first time-point image.
Statistics and quantization
Inter-kinetochore distances were measured only between sister kinetochore 
pairs on the spindle equator when both kinetochore dots were in the same 
optical section. Distance was defined as the space between the distal ends 
of the two ACA dots. Mad2 intensity was determined using the method of 
Hoffman et al. (2001). In brief, immunofluorescence image stacks were   
acquired using 300-nm steps on the DeltaVision System (Applied Precision, 
LLC) and the acquisition settings were the same for all samples. Because 
the distance between the sister kinetochores was too close to measure sep-
arately  after  depolymerizing  MTs  with  nocodazole,  sister  kinetochores 
pairs were analyzed. The best in-focus image from a non-deconvolved   
z-series  was  chosen  and  only  sister  kinetochores  in  the  same  section 
(horiziontal orientation) were selected for quantization. The intensity of 
Mad2 was normalized to the ACA level of the corresponding kinetochore 
pair, and 100 kinetochore pairs were examined from each of three sepa-
rate experiments. The relative fluorescence intensity was obtained by con-
verting the average intensity from nocodazole-treated cells to 1 and then JCB • VOLUME 186 • NUMBER 5 • 2009   684
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